Search Results 81-90 of 17165 for Glucagon

  1. Insulin nph and regular (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Also, check your blood for low blood sugar. Glucagon is used in emergency situations when severe symptoms including seizures or unconsciousness occur. Have a ...

  2. Publications - Lindsay R. Guevara, M.D. - Mayo Clinic

    Hunter Guevara LR, Beam WBB, Pasternak JJ. To the Brain and Beyond: Neurological Implications of Glucagon-Like Peptide-1 Receptor Agonists. J Neurosurg ...

  3. Endocrinology, Diabetes and Metabolism Training Program student roster - Mayo Clinic Research

    Jon David Adams, Ph.D. Adrian Vella, M.D., Understanding the interaction of glucagon and insulin secretion to determine postprandial glucose concentrations in ...

  4. Insulin aspart protamine and insulin aspart (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Have a glucagon kit and a syringe and needle available in case severe low blood sugar occurs. Check and replace any expired kits regularly. This medicine ...

  5. Tolbutamide (oral route) - Side effects & dosage - Mayo Clinic

    Glucagon is used in emergency situations when severe symptoms such as seizures (convulsions) or unconsciousness occur. Have a glucagon kit available, along ...

  6. Mayo Clinic Q and A: Weight loss and genetics

    Signals from the gut to the brain are hormones, such as glucagon-like peptide-1 (GLP-1). Semaglutide medications such as Wegovy, Ozempic and Rybelsus work ...

  7. Diabetic coma - Symptoms & causes - Mayo Clinic

    Have glucagon and fast-acting sources of sugar available. If you take insulin for your diabetes, have an up-to-date glucagon kit and fast-acting sources of ...

  8. Publications - Zach J. Fleissner, D.O. - Mayo Clinic

    Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia. Anesth Analg. 2025 Oct 1 ...

  9. Mayo Clinic expert responds to new Type 2 diabetes guidelines

    Furthermore, by confining the recommendations to oral medications, another class of injectable medication – glucagon-like peptide-1 receptor agonists - is ...

  10. Mayo Clinic, Carnegie Mellon researchers secure ARPA-H award for multiyear implantable device research for diabetes and obesity

    The goal for the device is to produce regulated levels of glucagon-like peptide 1 (GLP-1)-based therapies, which can improve glucose levels in patients with ...